RecruitingPhase 2NCT06038630

129Xe MRI Cardiopulmonary

129Xe Gas Exchange MRI to Visualize Cardiopulmonary Function


Sponsor

Bastiaan Driehuys

Enrollment

125 participants

Start Date

Jan 12, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this NIH-sponsored study is to characterize three biomarkers derived from 129Xe gas exchange MRI and to understand how they change in response to interventions.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is using a special type of MRI that uses inhaled xenon-129 gas to take detailed pictures of the lungs and heart. Researchers want to understand how breathing and blood flow in the lungs differ between healthy people and those with certain medical conditions. **You may be eligible if (healthy volunteer)...** - You are 18 or older with no diagnosed lung conditions - You have not smoked in the past 5 years and have less than 5 pack-years of smoking history - You have not regularly used inhaled products (like e-cigarettes) **You may be eligible if (patient)...** - You are 18 or older and have a condition such as heart failure, sickle cell disease, lung disease, or are undergoing blood transfusion or phlebotomy **You may NOT be eligible if...** - You have active infections or contraindications to MRI - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGHyperpolarized Xe129

Hyperpolarized xenon will be administered in multiple doses in volumes up to 25% of subject TLC followed by a breath hold of up to 15 seconds.

OTHEROxygen Administration

Oxygen administration


Locations(1)

Duke University Medical Center

Durham, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06038630


Related Trials